风湿免疫科

订阅

MedSci主页 / 所有栏目 / 风湿免疫科

风湿免疫自身免疫抗体进展

2021-11-05 张磊 岭南风湿

TPOAb抗核抗体抗中性粒细胞胞质抗体
关注

自身抗体是针对自身组织、器官、细胞及细胞成分的自身抗体，如果自身抗体的滴度超过正常水平，就可能对身体产生损伤，诱发疾病。本文对自身抗体相关的研究进展做一个综述。

图片

图片

图片

图片

图片

图片

图片

图片

图片

图片

图片

图片

图片

评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1219022, encodeId=f0a81219022de, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7aaa6498715, createdName=ms5000000932441984, createdTime=Thu May 12 11:56:49 CST 2022, time=2022-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194243, encodeId=fea111942436e, content=<a href='/topic/show?id=f61b2894204' target=_blank style='color:#2F92EE;'>#免疫#</a>与<a href='/topic/show?id=bac8100834b5' target=_blank style='color:#2F92EE;'>#风湿病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28942, encryptionId=f61b2894204, topicName=免疫), TopicDto(id=100834, encryptionId=bac8100834b5, topicName=风湿病)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Wed Feb 16 22:57:53 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187490, encodeId=02a7118e4906f, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eof7QgiaM40Cbk9nEupXmSOY1ibC6icYDYgtF7MMZoDnic7g0cyKqthJ2NLxE1WSiaib43H9DE4iaNQPFUBg/132, createdBy=9f9f5279032, createdName=李继鹏, createdTime=Sun Jan 23 17:38:29 CST 2022, time=2022-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1670458, encodeId=2b6416e0458b3, content=<a href='/topic/show?id=e2d110081540' target=_blank style='color:#2F92EE;'>#风湿免疫#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100815, encryptionId=e2d110081540, topicName=风湿免疫)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e49426693780, createdName=nakerunner, createdTime=Sun Nov 28 17:09:26 CST 2021, time=2021-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067860, encodeId=7c65106e86069, content=学习了<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210824/0129edd25da34fd4ab94ad0a178c2a63/17d82f91f91640318b49f92cf918d543.jpg, createdBy=208d102754, createdName=含子, createdTime=Sun Nov 07 17:56:43 CST 2021, time=2021-11-07, status=1, ipAttribution=)]
    2022-05-12 ms5000000932441984

    学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1219022, encodeId=f0a81219022de, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7aaa6498715, createdName=ms5000000932441984, createdTime=Thu May 12 11:56:49 CST 2022, time=2022-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194243, encodeId=fea111942436e, content=<a href='/topic/show?id=f61b2894204' target=_blank style='color:#2F92EE;'>#免疫#</a>与<a href='/topic/show?id=bac8100834b5' target=_blank style='color:#2F92EE;'>#风湿病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28942, encryptionId=f61b2894204, topicName=免疫), TopicDto(id=100834, encryptionId=bac8100834b5, topicName=风湿病)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Wed Feb 16 22:57:53 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187490, encodeId=02a7118e4906f, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eof7QgiaM40Cbk9nEupXmSOY1ibC6icYDYgtF7MMZoDnic7g0cyKqthJ2NLxE1WSiaib43H9DE4iaNQPFUBg/132, createdBy=9f9f5279032, createdName=李继鹏, createdTime=Sun Jan 23 17:38:29 CST 2022, time=2022-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1670458, encodeId=2b6416e0458b3, content=<a href='/topic/show?id=e2d110081540' target=_blank style='color:#2F92EE;'>#风湿免疫#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100815, encryptionId=e2d110081540, topicName=风湿免疫)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e49426693780, createdName=nakerunner, createdTime=Sun Nov 28 17:09:26 CST 2021, time=2021-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067860, encodeId=7c65106e86069, content=学习了<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210824/0129edd25da34fd4ab94ad0a178c2a63/17d82f91f91640318b49f92cf918d543.jpg, createdBy=208d102754, createdName=含子, createdTime=Sun Nov 07 17:56:43 CST 2021, time=2021-11-07, status=1, ipAttribution=)]
    2022-02-16 医者仁者

    #免疫#与#风湿病#

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1219022, encodeId=f0a81219022de, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7aaa6498715, createdName=ms5000000932441984, createdTime=Thu May 12 11:56:49 CST 2022, time=2022-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194243, encodeId=fea111942436e, content=<a href='/topic/show?id=f61b2894204' target=_blank style='color:#2F92EE;'>#免疫#</a>与<a href='/topic/show?id=bac8100834b5' target=_blank style='color:#2F92EE;'>#风湿病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28942, encryptionId=f61b2894204, topicName=免疫), TopicDto(id=100834, encryptionId=bac8100834b5, topicName=风湿病)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Wed Feb 16 22:57:53 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187490, encodeId=02a7118e4906f, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eof7QgiaM40Cbk9nEupXmSOY1ibC6icYDYgtF7MMZoDnic7g0cyKqthJ2NLxE1WSiaib43H9DE4iaNQPFUBg/132, createdBy=9f9f5279032, createdName=李继鹏, createdTime=Sun Jan 23 17:38:29 CST 2022, time=2022-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1670458, encodeId=2b6416e0458b3, content=<a href='/topic/show?id=e2d110081540' target=_blank style='color:#2F92EE;'>#风湿免疫#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100815, encryptionId=e2d110081540, topicName=风湿免疫)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e49426693780, createdName=nakerunner, createdTime=Sun Nov 28 17:09:26 CST 2021, time=2021-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067860, encodeId=7c65106e86069, content=学习了<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210824/0129edd25da34fd4ab94ad0a178c2a63/17d82f91f91640318b49f92cf918d543.jpg, createdBy=208d102754, createdName=含子, createdTime=Sun Nov 07 17:56:43 CST 2021, time=2021-11-07, status=1, ipAttribution=)]
    2022-01-23 李继鹏

    学习了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1219022, encodeId=f0a81219022de, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7aaa6498715, createdName=ms5000000932441984, createdTime=Thu May 12 11:56:49 CST 2022, time=2022-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194243, encodeId=fea111942436e, content=<a href='/topic/show?id=f61b2894204' target=_blank style='color:#2F92EE;'>#免疫#</a>与<a href='/topic/show?id=bac8100834b5' target=_blank style='color:#2F92EE;'>#风湿病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28942, encryptionId=f61b2894204, topicName=免疫), TopicDto(id=100834, encryptionId=bac8100834b5, topicName=风湿病)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Wed Feb 16 22:57:53 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187490, encodeId=02a7118e4906f, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eof7QgiaM40Cbk9nEupXmSOY1ibC6icYDYgtF7MMZoDnic7g0cyKqthJ2NLxE1WSiaib43H9DE4iaNQPFUBg/132, createdBy=9f9f5279032, createdName=李继鹏, createdTime=Sun Jan 23 17:38:29 CST 2022, time=2022-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1670458, encodeId=2b6416e0458b3, content=<a href='/topic/show?id=e2d110081540' target=_blank style='color:#2F92EE;'>#风湿免疫#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100815, encryptionId=e2d110081540, topicName=风湿免疫)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e49426693780, createdName=nakerunner, createdTime=Sun Nov 28 17:09:26 CST 2021, time=2021-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067860, encodeId=7c65106e86069, content=学习了<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210824/0129edd25da34fd4ab94ad0a178c2a63/17d82f91f91640318b49f92cf918d543.jpg, createdBy=208d102754, createdName=含子, createdTime=Sun Nov 07 17:56:43 CST 2021, time=2021-11-07, status=1, ipAttribution=)]
    2021-11-28 nakerunner

    #风湿免疫#

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1219022, encodeId=f0a81219022de, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7aaa6498715, createdName=ms5000000932441984, createdTime=Thu May 12 11:56:49 CST 2022, time=2022-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194243, encodeId=fea111942436e, content=<a href='/topic/show?id=f61b2894204' target=_blank style='color:#2F92EE;'>#免疫#</a>与<a href='/topic/show?id=bac8100834b5' target=_blank style='color:#2F92EE;'>#风湿病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28942, encryptionId=f61b2894204, topicName=免疫), TopicDto(id=100834, encryptionId=bac8100834b5, topicName=风湿病)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Wed Feb 16 22:57:53 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187490, encodeId=02a7118e4906f, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eof7QgiaM40Cbk9nEupXmSOY1ibC6icYDYgtF7MMZoDnic7g0cyKqthJ2NLxE1WSiaib43H9DE4iaNQPFUBg/132, createdBy=9f9f5279032, createdName=李继鹏, createdTime=Sun Jan 23 17:38:29 CST 2022, time=2022-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1670458, encodeId=2b6416e0458b3, content=<a href='/topic/show?id=e2d110081540' target=_blank style='color:#2F92EE;'>#风湿免疫#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100815, encryptionId=e2d110081540, topicName=风湿免疫)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e49426693780, createdName=nakerunner, createdTime=Sun Nov 28 17:09:26 CST 2021, time=2021-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067860, encodeId=7c65106e86069, content=学习了<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210824/0129edd25da34fd4ab94ad0a178c2a63/17d82f91f91640318b49f92cf918d543.jpg, createdBy=208d102754, createdName=含子, createdTime=Sun Nov 07 17:56:43 CST 2021, time=2021-11-07, status=1, ipAttribution=)]
    2021-11-07 含子

    学习了#学习#

    0

相关资讯

TPOAb、TGAb、TRAb的“同”与“异”

目前临床使用的甲状腺自身抗体主要包括TPOAb、TGAb和TRAb，虽然它们都主要用于甲状腺疾病病因学诊断，但其在临床上的意义并不相同，需要我们认真分析，下面我们对三个抗体的临床意义进行了归纳和总结。

JCEM：妊娠早期甲状腺功能和TPOAb对妊娠结局的影响

由此可见，妊娠早期TSH为2.5-4.08 mIU/L联合TPOAb（-）与流产和孕产妇综合结局相关。在TSH为2.5-4.08 mIU/L的孕妇中使用L-T4的优缺点仍不确定。